A carregar...
CSNK1α1 mediates malignant plasma cell survival
Here we report that targeting casein kinase 1 (CSNK1α1) is a potential novel treatment strategy in multiple myeloma (MM) therapy distinct from proteasome inhibition. CSNK1α1 is expressed in all the tested MM cell lines and patient MM cells, and is not altered during bortezomib-triggered cytotoxicity...
Na minha lista:
| Publicado no: | Leukemia |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4276736/ https://ncbi.nlm.nih.gov/pubmed/24962017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2014.202 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|